Supporting dementia patients in hospital environments: health-related risks, needs and dedicated structures for patient care

2014 ◽  
Vol 22 (2) ◽  
pp. 239-e18 ◽  
Author(s):  
D. M. Hermann ◽  
S. Muck ◽  
H.-G. Nehen
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Nina Tusa ◽  
Hannu Kautiainen ◽  
Pia Elfving ◽  
Sanna Sinikallio ◽  
Pekka Mäntyselkä

Abstract Backround Chronic diseases and multimorbidity are common in the ageing population and affect the health related quality of life. Health care resources are limited and the continuity of care has to be assured. Therefore it is essential to find demonstrable tools for best treatment practices for patients with chronic diseases. Our aim was to study the influence of a participatory patient care plan on the health-related quality of life and disease specific outcomes related to diabetes, ischemic heart disease and hypertension. Methods The data of the present study were based on the Participatory Patient Care Planning in Primary Care. A total of 605 patients were recruited in the Siilinjärvi Health Center in the years 2017–2018 from those patients who were followed up due to the treatment of hypertension, ischemic heart disease or diabetes. Patients were randomized into usual care and intervention groups. The intervention consisted of a participatory patient care plan, which was formulated in collaboration with the patient and the nurse and the physician during the first health care visit. Health-related quality of life with the 15D instrument and the disease-specific outcomes of body mass index (BMI), low density lipoprotein cholesterol (LDL-C), hemoglobin A1c (HbA1C) and blood pressure were assessed at the baseline and after a one-year follow-up. Results A total of 587 patients with a mean age of 69 years were followed for 12 months. In the intervention group there were 289 patients (54% women) and in the usual care group there were 298 patients (50% women). During the follow-up there were no significant changes between the groups in health-related quality and disease-specific outcomes. Conclusions During the 12-month follow-up, no significant differences between the intervention and the usual care groups were detected, as the intervention and the usual care groups were already in good therapeutic equilibrium at the baseline. Trial registration ClinicalTrials.gov Identifier: NCT02992431. Registered 14/12/2016


Author(s):  
Haneen Amawi ◽  
Sayer Alazzam ◽  
Tasnim Alzanati ◽  
Neveen Altamimi ◽  
Alaa Hammad ◽  
...  

Background: The use of health-related applications (apps) on smartphones has become widespread. This is especially of value during the ongoing SAR-COV-2 pandemic, where the accessibility for health care services has been greatly limited. Patients with free access to apps can obtain information to improve their understanding and management of health issues. Currently, there are cancer-related apps available on iPhones and androids. However, there are no guidelines to control these apps and ensure their quality. Furthermore, these apps may significantly modify the patients’ perception and knowledge toward drug-related health services. Objective: The aim of this study was to assess the convenience, quality, safety and efficacy of apps for cancer patient care. Methods: The study was conducted by searching all apps related to cancer care on both Google Play Store and Apple iTunes Store. A detailed assessment was then performed using the mobile application rating scale (MARS) and risk assessment tools. Results: The results indicated that on a scale from 1-5, 47% of the apps were rated ≥ 4. The MARS assessment of the apps indicated an overall quality rating of 3.38 ± 0.9 (mean ± SD). The visual appeal of the app was found to have a significant effect on app functionality and user engagement. The potential benefits of these apps come with challenges and limitations. Patents related to smartphone applications targeting patients were also discussed. Conclusion: We recommend a greater emphasis toward producing evidence-based apps. These apps should be rigorously tested, evaluated and updated by experts, particularly clinical pharmacists. Also, these may alter patient attitudes toward services provided by physicians and pharmacists. Finally, these apps should not replace in-person interactive health services.


Author(s):  
Paul G. Ronco

Human factors specialists who conduct research on the design of hospitals should consider the needs of patients, not just those of doctors, nurses, and other staff. Patients are subject to physical and psychological confinement, lack of privacy, lack of familiar support, and disruption of familiar behavior patterns, all contributing to loss of personal control and an increase in the stress from hospitalization. To help design better hospital environments for patients, it will be necessary to identify relationships between particular environmental features, subjective reactions to these, and overt behaviors which such features influence. A start in this direction has been made by means of the semantic differential.


Author(s):  
Valeri Sáenz ◽  
Carlos Alvarez-Moreno ◽  
Patrice Le Pape ◽  
Silvia Restrepo ◽  
Josep Guarro ◽  
...  

A strategy to propose solutions to health-related problems recognizes that people, animals, and the environment are interconnected. Fusarium and Neocosmospora are an example of this interaction due to the capable of infecting plants, animals, and human. This review provides information on various aspects of these relations and proposes how to approach fusariosis with a One Health methodology. Here we give a framework to understand infection pathogenesis, through the epidemiological triad and explain how the broad utilization of fungicides in agriculture may play a role in the treatment of human fusariosis. We assess how plumbing systems and hospital environments might play a role as a reservoir for animal and human infections. We explain the role of antifungal resistance mechanism in both humans and agriculture. Our review emphasizes the importance of developing interdisciplinarity research studies where aquatic animals, plants, and human disease interactions can be explored through coordination and collaborative actions.


2020 ◽  
Vol 6 (4) ◽  
pp. 235
Author(s):  
Valeri Sáenz ◽  
Carlos Alvarez-Moreno ◽  
Patrice Le Pape ◽  
Silvia Restrepo ◽  
Josep Guarro ◽  
...  

Any strategy that proposes solutions to health-related problems recognizes that people, animals, and the environment are interconnected. Fusarium is an example of this interaction because it is capable of infecting plants, animals, and humans. This review provides information on various aspects of these relations and proposes how to approach fusariosis with a One Health methodology (a multidisciplinary, and multisectoral approach that can address urgent, ongoing, or potential health threats to humans, animals, and the environment). Here, we give a framework to understand infection pathogenesis, through the epidemiological triad, and explain how the broad utilization of fungicides in agriculture may play a role in the treatment of human fusariosis. We assess how plumbing systems and hospital environments might play a role as a reservoir for animal and human infections. We explain the role of antifungal resistance mechanisms in both humans and agriculture. Our review emphasizes the importance of developing interdisciplinary research studies where aquatic animals, plants, and human disease interactions can be explored through coordination and collaborative actions.


2019 ◽  
Vol 76 (Suppl 1) ◽  
pp. A91.3-A92
Author(s):  
Gautham Sukumar ◽  
Kowshik Kupatira ◽  
Pradeep Banandur ◽  
G Gururaj

IntroductionThis ‘Health and productivity’ project was implemented to identify priority health problems and health related productivity loss in a large automobile industry in India. It hopes to re-emphasize that ‘OH department’ is a partner in productivity.ObjectivesTo estimate prevalence, incidence rates , trends and risk for health problems among employees (year 2010–14)To identify leading causes of hospitalization and out–patient care among employees (year 2010–14).To quantify loss in productive work time attributed to health related absence in year 2014 and forecast to year 2025MethodsA five year records analysis (2010–14) was conducted in a leading automobile industry in year 2015–16. Data was pooled from clinic visit records, annual medical examination , insurance claims and leave records, systematically using employee ID. Trends and incidence rates of leading health risks were computed per 1000 person-months of employment. Leading causes and trends in out-patient and in-patient care of employees were determined. Total work time (man-hours) was computed and health related loss in work-time was derived. Cox-regression was used to assess risk between work department and morbidity. ARIMA method was used to forecast productivity loss till year 2025.ResultsBetween 2010–14, overweight and hypertension were identified as leading health risks. Respiratory, musculoskeletal and digestive disorders were leading causes for clinic visits. Infectious diseases are leading cause for hospitalization. Health related absence accounted for 1.87% of total productive time. Forecasting indicates an increase to 9.31% by year 2025.ConclusionHealth related absence contributes to significant loss in productive work-time. There is scope to reduce these losses by improvement in health situation. Our study provided key information and trends for planning evidence based health promotion programmes in the industry.


2016 ◽  
Vol 43 (7) ◽  
pp. 1292-1299 ◽  
Author(s):  
Johan K. Wallman ◽  
Jonas K. Eriksson ◽  
Jan-Åke Nilsson ◽  
Tor Olofsson ◽  
Lars-Erik Kristensen ◽  
...  

Objective.To compare how costs relate to disability, disease activity, and health-related quality of life (HRQOL) in rheumatoid arthritis (RA).Methods.Antitumor necrosis factor (anti-TNF)-treated patients with RA in southern Sweden (n = 2341) were monitored 2005–2010. Health Assessment Questionnaire (HAQ), 28-joint Disease Activity Score (DAS28), and EQ-5D scores were linked to register-derived costs of antirheumatic drugs (excluding anti-TNF agents), patient care, and work loss from 30 days before to 30 days after each visit (n = 13,289). Associations of HAQ/DAS28/EQ-5D to healthcare (patient care and drugs) and work loss costs (patients < 65 yrs) were studied in separate regression models, comparing standardized β coefficients by nonparametric bootstrapping to assess which measure best reflects costs. Analyses were conducted based on both individual means (linear regression, comparing between-patient associations) and by generalized estimating equations (GEE), using all observations to also account for within-patient associations of HAQ/DAS28/EQ-5D to costs.Results.Regardless of the methodology (linear or GEE regression), HAQ was most closely related to both cost types, while work loss costs were also more closely associated with EQ-5D than DAS28. The results of the linear models for healthcare costs were standardized β = 0.21 (95% CI 0.15–0.27), 0.16 (0.11–0.21), and –0.15 (−0.21 to −0.10) for HAQ/DAS28/EQ-5D, respectively (p < 0.05 for HAQ vs DAS28/EQ-5D). For work loss costs, the results were standardized β = 0.43 (95% CI 0.39–0.48), 0.27 (0.23–0.32), and −0.34 (−0.38 to −0.29) for HAQ/DAS28/EQ-5D, respectively (p < 0.05 for HAQ vs DAS28/EQ-5D and for EQ-5D vs DAS28).Conclusion.Overall, HAQ disability is a better marker of RA costs than DAS28 or EQ-5D HRQOL.


Sign in / Sign up

Export Citation Format

Share Document